An Interview with Ian Holloway, MHRA: A Regulatory Response to New Temperature Monitoring Technologies

Posted: 05/30/2011

"We are seeing now a lot of new technologies and service providers for the cold chain which has great benefits for companies to adopt. If they bring these in-house they can increase standards and increasingly the regulators are expecting companies to do this and to invest in improving their own systems," Ian Holloway, Manager, Defective Medicines Reporting Centre, MHRA, shares his insights with Pharma IQ, at IQPC's 10th Annual Cool Chain Europe 2011. Watch now for more...

To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.